This suggests the potential for FFAR4 activation to extend from monocytes to resident adipose tissue macrophages, which could have implications in promoting pro-resolving mechanisms and improving insulin sensitivity, thereby modulating the inflammatory response in obesity. The gene discussed is FFAR4; the disease is obesity due to melanocortin 4 receptor deficiency.